AMGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 270 USD | +0.22% |
|
+0.39% | -6.26% |
| Apr. 26 | Amgen to Submit Thyroid Eye Disease Treatment Marketing Authorization Application in Europe | MT |
| Apr. 26 | Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | +0.22% | +0.39% | -6.26% | +13.06% | +48.77% | 145B |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- AMGN Stock
- Charts Amgen Inc.
- Comparison Chart
